Filed: 8/15/2024ACC: 0000950123-24-008845
📋 What this filing means
BLUE OWL CAPITAL HOLDINGS LP filed this quarterly 13F‑HR report disclosing 41 equity positions with a total reported market value of $359.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
41
Positions
$359.56M
Total AUM (reported)
50.01M
Total Shares
Allocation by class
COM$285.73M79.5%
COM SER A$35.55M9.9%
CL A$9.17M2.5%
COM CL A$7.72M2.1%
SHS$6.61M1.8%
COMMON STOCK$5.65M1.6%
SPON ADS$3.23M0.9%
Portfolio Concentration
Top 3$99.44M27.7%
4–10$145.03M40.3%
11–25$95.73M26.6%
Rest$19.36M5.4%
Top 3 weight
27.7%
Top 10 weight
68.0%
Voting Authority Distribution
Total shares with voting rights: 0.00
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other41
Dominant voting typeNone · 0.0% of voting shares
Institutional Holdings41
Rows:
CULLINAN THERAPEUTICS INC
DFNDShares2.05M
TypeSH
Market value$35.74M
9.94%
Sole
0.00
Shared
0.00
None
0.00
PLIANT THERAPEUTICS INC
DFNDShares3M
TypeSH
Market value$32.30M
8.98%
Sole
0.00
Shared
0.00
None
0.00
BLUE OWL CAPITAL CORPORATION
DFNDShares2.05M
TypeSH
Market value$31.41M
8.74%
Sole
0.00
Shared
0.00
None
0.00
KLAVIYO INC
DFNDShares1.20M
TypeSH
Market value$29.82M
8.29%
Sole
0.00
Shared
0.00
None
0.00
LARIMAR THERAPEUTICS INC
DFNDShares3.86M
TypeSH
Market value$27.98M
7.78%
Sole
0.00
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
DFNDShares2.45M
TypeSH
Market value$23.10M
6.43%
Sole
0.00
Shared
0.00
None
0.00
TOURMALINE BIO INC
DFNDShares1.72M
TypeSH
Market value$22.06M
6.14%
Sole
0.00
Shared
0.00
None
0.00
EVERCOMMERCE INC
DFNDShares1.64M
TypeSH
Market value$18.03M
5.01%
Sole
0.00
Shared
0.00
None
0.00
ACELYRIN INC
DFNDShares2.93M
TypeSH
Market value$12.90M
3.59%
Sole
0.00
Shared
0.00
None
0.00
REPARE THERAPEUTICS INC
DFNDShares3.37M
TypeSH
Market value$11.13M
3.10%
Sole
0.00
Shared
0.00
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares268.24K
TypeSH
Market value$11.02M
3.07%
Sole
0.00
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
DFNDShares5.16M
TypeSH
Market value$10.35M
2.88%
Sole
0.00
Shared
0.00
None
0.00
DISC MEDICINE INC
DFNDShares215.26K
TypeSH
Market value$9.70M
2.70%
Sole
0.00
Shared
0.00
None
0.00
TOAST INC
DFNDShares322.58K
TypeSH
Market value$8.31M
2.31%
Sole
0.00
Shared
0.00
None
0.00
E2OPEN PARENT HOLDINGS INC
DFNDShares1.65M
TypeSH
Market value$7.41M
2.06%
Sole
0.00
Shared
0.00
None
0.00
KEROS THERAPEUTICS INC
DFNDShares157.63K
TypeSH
Market value$7.20M
2.00%
Sole
0.00
Shared
0.00
None
0.00
IKENA ONCOLOGY INC
DFNDShares4.09M
TypeSH
Market value$6.75M
1.88%
Sole
0.00
Shared
0.00
None
0.00
SAGIMET BIOSCIENCES INC
DFNDShares1.67M
TypeSH
Market value$5.72M
1.59%
Sole
0.00
Shared
0.00
None
0.00
MINERALYS THERAPEUTICS INC
DFNDShares450.34K
TypeSH
Market value$5.27M
1.47%
Sole
0.00
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
DFNDShares95K
TypeSH
Market value$5.04M
1.40%
Sole
0.00
Shared
0.00
None
0.00
INOZYME PHARMA INC
DFNDShares1.12M
TypeSH
Market value$5.00M
1.39%
Sole
0.00
Shared
0.00
None
0.00
STARWOOD PROPERTY TRUST
DFNDShares226.46K
TypeSH
Market value$4.29M
1.19%
Sole
0.00
Shared
0.00
None
0.00
PYXIS ONCOLOGY INC
DFNDShares1.05M
TypeSH
Market value$3.46M
0.96%
Sole
0.00
Shared
0.00
None
0.00
MEREO BIOPHARMA GROUP PLC
DFNDShares897.81K
TypeSH
Market value$3.23M
0.90%
Sole
0.00
Shared
0.00
None
0.00
AQUESTIVE THERAPEUTICS INC
DFNDShares1.14M
TypeSH
Market value$2.96M
0.82%
Sole
0.00
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CULLINAN THERAPEUTICS INCDFND | COM | 2.05M | SH | $35.74M 9.94% | 0.00 | 0.00 | 0.00 |
PLIANT THERAPEUTICS INCDFND | COM | 3M | SH | $32.30M 8.98% | 0.00 | 0.00 | 0.00 |
BLUE OWL CAPITAL CORPORATIONDFND | COM | 2.05M | SH | $31.41M 8.74% | 0.00 | 0.00 | 0.00 |
KLAVIYO INCDFND | COM SER A | 1.20M | SH | $29.82M 8.29% | 0.00 | 0.00 | 0.00 |
LARIMAR THERAPEUTICS INCDFND | COM | 3.86M | SH | $27.98M 7.78% | 0.00 | 0.00 | 0.00 |
ENGENE HOLDINGS INCDFND | COM | 2.45M | SH | $23.10M 6.43% | 0.00 | 0.00 | 0.00 |
TOURMALINE BIO INCDFND | COM | 1.72M | SH | $22.06M 6.14% | 0.00 | 0.00 | 0.00 |
EVERCOMMERCE INCDFND | COM | 1.64M | SH | $18.03M 5.01% | 0.00 | 0.00 | 0.00 |
ACELYRIN INCDFND | COM | 2.93M | SH | $12.90M 3.59% | 0.00 | 0.00 | 0.00 |
REPARE THERAPEUTICS INCDFND | COM | 3.37M | SH | $11.13M 3.10% | 0.00 | 0.00 | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 268.24K | SH | $11.02M 3.07% | 0.00 | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCDFND | COM | 5.16M | SH | $10.35M 2.88% | 0.00 | 0.00 | 0.00 |
DISC MEDICINE INCDFND | COM | 215.26K | SH | $9.70M 2.70% | 0.00 | 0.00 | 0.00 |
TOAST INCDFND | CL A | 322.58K | SH | $8.31M 2.31% | 0.00 | 0.00 | 0.00 |
E2OPEN PARENT HOLDINGS INCDFND | COM CL A | 1.65M | SH | $7.41M 2.06% | 0.00 | 0.00 | 0.00 |
KEROS THERAPEUTICS INCDFND | COM | 157.63K | SH | $7.20M 2.00% | 0.00 | 0.00 | 0.00 |
IKENA ONCOLOGY INCDFND | COM | 4.09M | SH | $6.75M 1.88% | 0.00 | 0.00 | 0.00 |
SAGIMET BIOSCIENCES INCDFND | COM SER A | 1.67M | SH | $5.72M 1.59% | 0.00 | 0.00 | 0.00 |
MINERALYS THERAPEUTICS INCDFND | COM | 450.34K | SH | $5.27M 1.47% | 0.00 | 0.00 | 0.00 |
VIKING THERAPEUTICS INCDFND | COM | 95K | SH | $5.04M 1.40% | 0.00 | 0.00 | 0.00 |
INOZYME PHARMA INCDFND | COM | 1.12M | SH | $5.00M 1.39% | 0.00 | 0.00 | 0.00 |
STARWOOD PROPERTY TRUSTDFND | SHS | 226.46K | SH | $4.29M 1.19% | 0.00 | 0.00 | 0.00 |
PYXIS ONCOLOGY INCDFND | COMMON STOCK | 1.05M | SH | $3.46M 0.96% | 0.00 | 0.00 | 0.00 |
MEREO BIOPHARMA GROUP PLCDFND | SPON ADS | 897.81K | SH | $3.23M 0.90% | 0.00 | 0.00 | 0.00 |
AQUESTIVE THERAPEUTICS INCDFND | COM | 1.14M | SH | $2.96M 0.82% | 0.00 | 0.00 | 0.00 |
Page 1 of 2